Fig. 1
24-h CGM data for 101 type 1 diabetic patients on basal-bolus insulin therapy as stratified equally by HbA1c value. Group A, HbA1c ≤7.2 %; group B, 7.2 % <HbA1c ≤8.2 %; group C, 8.2 % <HbA1c ≤ 9.2 %; and group D, HbA1c >9.2 %
Fig. 1 | Diabetology & Metabolic Syndrome